David Scully, BSc, MSc, Dipl., PhD
About David Scully, BSc, MSc, Dipl., PhD
David Scully is the New Product Introduction Procurement Lead at Bristol Myers Squibb in Dublin, Ireland, with extensive experience in pharmaceuticals and biomedical sciences.
Title and Role at Bristol Myers Squibb
David Scully currently holds the position of New Product Introduction Procurement Lead at Bristol Myers Squibb in Dublin, County Dublin, Ireland. In this role, he leads the material qualification and business continuity efforts for a novel immuno-inflammation product targeting rare diseases. He also conducts procurement deviation assessments and root cause analysis on product defaults, enhancing vendor management processes. Additionally, he has developed a data repository for compliance and business continuity in the context of new product introduction.
Previous Experience at BAP Pharma
From 2019 to 2021, David served as a Business Project Manager at BAP Pharma in Slough, United Kingdom. During his tenure, he was responsible for managing multiple projects and ensuring their successful delivery. His role likely involved cross-functional coordination, project planning, and stakeholder management to meet organizational objectives.
Academic Background and Qualifications
David holds an extensive academic background in medical and biomedical sciences. He earned his Doctor of Philosophy (PhD) in Medical Sciences from The University of Hull, where he studied from 2016 to 2019. Prior to that, he completed a Master of Science (MSc) in Stem Cells & Regenerative Medicine from Aston University between 2014 and 2015. David also has a Bachelor of Science (BSc) in Health and Performance Science from University College Dublin (2011-2014) and a Postgraduate Diploma in Research Training in Biomedical Sciences from the University of York.
Industry Certifications and Skills
David holds a Yellow Belt Lean certification, demonstrating his expertise in process improvement methodologies. This qualification underscores his ability to streamline processes and enhance operational efficiency, aligning with his roles in procurement and project management.
Research and Mentorship
David has made significant contributions to the field of regenerative medicine, including publishing research on human platelet releasate therapy and stem cell regeneration. His work in these areas aims to identify new targets for drug discovery. He has also mentored final-year medical students and doctors, sharing his expertise in biomedical science and regenerative medicine. Furthermore, David has actively collaborated with international laboratories, clinics, and pharmaceutical industries, establishing a robust network of key opinion leaders.